Evidence map›Paper›PMID 22926061›Full record

ArticleCancer immunology, immunotherapy : CII2013

The role of gamma interferon in DNA vaccine-induced tumor immunity targeting simian virus 40 large tumor antigen.

Joel F Aldrich, Michael H Shearer, Devin B Lowe, Richard E Winn, Cynthia A Jumper, Ronald C Kennedy, Robert K Bright

Open access · greenAbstract read
In one paragraph

Article in Cancer immunology, immunotherapy : CII, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Joel F AldrichDepartment of Immunology and Molecular Microbiology, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.
Michael H Shearer
Devin B Lowe
Richard E Winn
Cynthia A Jumper
Ronald C Kennedy
Robert K Bright
Texas Tech University Health Sciences Center · USTexas Tech University · US

Funding

CORE--BABOON RESEARCH RESOURCE PROGRAMP40RR012317 · NCRR · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI WHITE, GARY L · 1998 to 2011
$13.0M
NCRR NIH HHS P40 RR012317NCRR NIH HHS RR-12317
6 · The paper itself

Abstract

The central role of CD4+ T lymphocytes in mediating DNA vaccine-induced tumor immunity against the viral oncoprotein simian virus 40 (SV40) large tumor antigen (Tag) has previously been described by our laboratory. In the present study, we extend our previous findings by examining the roles of IFN-γ and Th1-associated effector cells within the context of DNA immunization in a murine model of pulmonary metastasis. Immunization of BALB/c mice with plasmid DNA encoding SV40 Tag (pCMV-Tag) generated IFN-γ-secreting T lymphocytes that produced this cytokine upon in vitro stimulation with mKSA tumor cells. The role of IFN-γ as a mediator of protection against mKSA tumor development was assessed via in vivo IFN-γ neutralization, and these experiments demonstrated a requirement for this cytokine in the induction immune phase. Neutralization of IFN-γ was associated with a reduction in Th1 cytokine-producing CD4+ and CD8+ splenocytes, as assessed by flow cytometry analysis, and provided further evidence for the role of CD4+ T lymphocytes as drivers of the cellular immune response. Depletion of NK cells and CD8+ T lymphocytes demonstrated the expendability of these cell types individually, but showed a requirement for a resident cytotoxic cell population within the immune effector phase. Our findings demonstrate the importance of IFN-γ in the induction of protective immunity stimulated by pCMV-Tag DNA-based vaccine and help to clarify the general mechanisms by which DNA vaccines trigger immunity to tumor cells.

Indexed as

AnimalsAntigens, Polyomavirus TransformingCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCells, CulturedCell Transformation, NeoplasticFemaleInterferon-gammaKidney NeoplasmsKiller Cells, NaturalLung NeoplasmsMiceMice, Inbred BALB CPlasmidsPolyomavirus InfectionsSimian virus 40Antigens, Polyomavirus TransformingInterferon-gammaVaccines, DNA

Identifiers

PMID22926061
PMCPMC11028630
OpenAlexW1991953735

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.